INTELGENX TECHNOLOGIES CORP. REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • March 28th, 2008 • IntelGenx Technologies Corp. • Pharmaceutical preparations • Delaware
This Registration Rights Agreement (this “Agreement”) is made and entered into as of the 27th day of March, 2008 between IntelGenx Technologies Corp., a Delaware corporation (the “Company”), and Paradigm Capital Inc. (the “Agent”).
March 27, 2008IntelGenx Technologies Corp. • March 28th, 2008 • Pharmaceutical preparations
INTELGENX TECHNOLOGIES CORP. AMENDING LETTER RE: SUBSCRIPTION AGREEMENT FOR UNITSIntelGenx Technologies Corp. • March 28th, 2008 • Pharmaceutical preparations
Reference is made to that subscription agreement (the “Subscription Agreement”) between the undersigned Subscriber, IntelGenx Technologies Corp. (“IntelGenx” or the “Corporation”) and the Agent, whereby the Subscriber agreed to purchase from the Corporation that number of Units set out therein at a price of US$0.70 per Unit. The parties to the Subscription Agreement have agreed to amend the terms of the Subscription Agreement (the “Amendment”) as follows:
AGENCY AGREEMENTAgency Agreement • March 28th, 2008 • IntelGenx Technologies Corp. • Pharmaceutical preparations • Ontario
The undersigned, Paradigm Capital Inc. (the “Agent”), understands that IntelGenx Technologies Corp. (the “Company”) proposes to issue and sell 4,001,000 units (individually a “Unit” and, collectively, the “Units”) having the terms described herein, at a price of US$0.70 per Unit (the “Issue Price”) for aggregate gross proceeds to the Company of US$2,800,700. The offering of Units is hereinafter referred to as the “Offering”. Each Unit shall be comprised of one share of common stock, par value US$0.00001 of the Company (a “Unit Share”) and one share purchase warrant (each whole share purchase warrant being a “Warrant”). Each Warrant will entitle the holder thereof to purchase one share of common stock, par value US$0.00001, of the Company (a “Warrant Share”) for a period of twenty-four (24) months following the Closing Date (as defined below) at a price of US$1.02. In the event that the Liquidity Conditions (as herein defined) are not met on or before the Penalty Date (as hereinafter de
INTELGENX TECHNOLOGIES CORP. SUBSCRIPTION AGREEMENT FOR UNITSIntelGenx Technologies Corp. • March 28th, 2008 • Pharmaceutical preparations • Ontario
The undersigned (the "Subscriber") hereby irrevocably subscribes for and agrees to purchase from IntelGenx Technologies Corp. (the "Corporation") that number of units in the capital of the Corporation (the "Units") set out below at a price of US$0.70 per Unit. Each Unit is comprised of one common share in the capital of the Corporation (the “Common Shares”) and one common share purchase warrant (a “Warrant”). Each Warrant shall entitle the holder thereof to purchase one Common Share (a “Warrant Share”) at a price of US$1.02 per Warrant Share for 24 months following the Closing Date (as herein defined). Each Warrant will be exercisable for one Warrant Share on the same terms but at a price of US$0.93 per Warrant Share in the event that IntelGenx does not satisfy the Liquidity Conditions (as herein defined) prior to 5:00 p.m. (Toronto time) on that date which is four months following the Closing Date (the “Penalty Date”). The Subscriber agrees to be bound by the terms and conditions set
